Efficient Synthesis of Potential Impurities in Levonadifloxacin (WCK 771)

Area of Science:

• Pharmaceutical Chemistry
• Analytical Chemistry
• Medicinal Chemistry

Background:

• Levonadifloxacin (WCK 771) is a new broad-spectrum antibiotic with activity against methicillin-resistant *Staphylococcus aureus* (MRSA).
• The drug has recently been launched in India, necessitating robust quality control measures.
• Commercially available reference standards for process and degradation impurities are often limited.

Purpose of the Study:

• To synthesize and characterize key process and degradation impurities of Levonadifloxacin.
• To establish reference standards for these impurities.
• To support the development of a high-performance liquid chromatography (HPLC) methodology for impurity quantification.

Main Methods:

• Chemical synthesis of five process impurities and one degradation impurity of Levonadifloxacin.
• Comprehensive characterization of the synthesized impurity compounds.
• Development and application of HPLC methodology for impurity analysis in drug substance and drug product.

Main Results:

• Successful synthesis and characterization of six critical Levonadifloxacin impurities.
• Availability of essential reference standards not previously accessible.
• Establishment of a validated HPLC method for quantifying these impurities.

Conclusions:

• The synthesized impurities serve as vital reference standards for Levonadifloxacin quality control.
• The developed HPLC method enables accurate quantification of impurities in drug substance and product.
• This work supports the reliable manufacturing and quality assurance of Levonadifloxacin.